Basic symptom-modifying delayed-action drugs in therapy of osteoporosis
نویسندگان
چکیده
منابع مشابه
Biologic Disease-Modifying Antirheumatic Drugs
1. Distinguish between biologic DMARD use and nonbiologic DMARD use in the treatment of rheumatoid arthritis (RA). 2. Assess the differences between classes of biologic disease-modifying antirheumatic drug (DMARD) therapy. 3. Based on individual patient characteristics, construct a treatment and monitoring plan for a patient with RA and, when appropriate, include biologic DMARD therapy. 4. Just...
متن کاملDIETARY SALT REDUCTION POTENTIATES THE ACTION OF HYPOTENSIVE DRUGS
Hypertension is a common health problem. Hypotensive drugs and low salt diet are used in its treatment. This study was designed to compare the effectiveness of a low-salt diet and drug therapy in the treatment of arterial hypertension. A total of 256 randomly selected patients with essential hypertension consulting the Non-contagious Diseases Clinic in Shahreza, Isfahan, Iran, were included...
متن کاملDisease-modifying Antirheumatic Drugs (DMARDs)
Therapy with disease-modifying antirheumatic drugs (DMARDs) should be started as soon as the diagnosis of rheumatoid arthritis (RA) is made. [1]The early use of DMARDs has been recommended in recent years to reduce disease progression and long-term disability. [2]The need for early use of DMARDs is incorporated in new National Institute for Health and Care Excellence (NICE) guidance. [3]Early u...
متن کاملDisease-modifying Antirheumatic Drugs (DMARDs)
Therapy with disease-modifying antirheumatic drugs (DMARDs) should be started as soon as the diagnosis of rheumatoid arthritis (RA) is made. [1]The early use of DMARDs has been recommended in recent years to reduce disease progression and long-term disability. [2]The need for early use of DMARDs is incorporated in new National Institute for Health and Care Excellence (NICE) guidance. [3]Early u...
متن کاملSelf-modifying Finite Automata | Basic Deenitions and Results Self-modifying Finite Automata | Basic Deenitions and Results
We formally de ne the Self-Modifying Finite Automaton (SMFA), a model of computation introduced in [RS93, RS94, RS95], as a subclass of a new more general model, the Self-Modifying Automaton (SMA). SMAs are similar to standard nite automata, but changes to the transition set are allowed during a computation. An SMFA is constrained in that it can have only nitely many di erent modi cation instru...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Modern Rheumatology Journal
سال: 2011
ISSN: 2310-158X,1996-7012
DOI: 10.14412/1996-7012-2011-687